摘要
[目的]分析ERCP合并EST对胆道疾病疗效及其并发症的发生情况、预防及处理方法。[方法]回顾性总结行ERCP合并EST 324例患者资料,分析其疗效及术中、术后发生并发症情况及处理结果。[结果]324例中7例ERCP操作失败,其总成功率97.8%,胆总管取石率97.8%,胆管良性狭窄治愈率93.7%,胆管炎治愈率89.4%,恶性胆道狭窄操作成功率85.7%,术中及术后发生并发症发生率分别为高淀粉酶血症51例(15.7%),术后胰腺炎13例(4%),术后胆管炎感染2例(0.6%),术后穿孔1例(0.3%),无出血及其他心肺并发症病例,无一例死亡。[结论]ERCP合并EST对胆道疾病治疗安全及疗效较好,严格掌握适应证,精准操作,避免危险因素,可减少术中、术后并发症,提高治疗安全性。
[Objective]Analysis the treatment effect and incidence, prevention of complications of endo- scopic retrograde cholangiopancreatography（ERCP） merger endoscopic-sphincterotomy（EST） on the biliary disease. [Methods]The totals of 324 patients underwent ERCP merger EST from Jan. 2012 to Apr. 2015 in our hospital were analyzed retrospectively. The treatment effect and complications and their treatment dur- ing and Post-ERCP merger EST were also analyzed,[Results]In this study,ERCP merger EST success rate was 97.8% ,choledocholithotomy rate was 97.8% ,benign bile duct stricture cure rate was 93.7% ,cholan- gitis cure rate was 89.4% ,malignant biliary stricture success rate was 85.70% ,hyperamylasemia during and postoperative was 51 （15.7 % ）, pancreatitis was 13 cases （4 % ）, postoperative cholangitis infection was 2 ca- ses（0.6 % ）, perforation was 1 case（0.3% ）, no cases of bleeding and other cardiopulmonary complications, no deaths. [Conclusion]ERCP merger EST has better safety and efficacy on the biliary disease,controlling the indications and contraindications of ERCP and EST. Skillful manipulation,avoiding related risk factors can be used to improve the overall quality and safety of ERCP.
出处
《临床消化病杂志》
2016年第2期76-78,共3页
Chinese Journal of Clinical Gastroenterology
关键词
内镜逆行性胰胆管造影术
内镜乳头括约肌切开术
疗效
并发症
endoscopic retrograde eholangiopancreatography
endoscopic-sphincterotomy
trer.cmenteffect
complications
